HN2010000313A - Pirimidinas biciclicas fusionadas - Google Patents
Pirimidinas biciclicas fusionadasInfo
- Publication number
- HN2010000313A HN2010000313A HN2010000313A HN2010000313A HN2010000313A HN 2010000313 A HN2010000313 A HN 2010000313A HN 2010000313 A HN2010000313 A HN 2010000313A HN 2010000313 A HN2010000313 A HN 2010000313A HN 2010000313 A HN2010000313 A HN 2010000313A
- Authority
- HN
- Honduras
- Prior art keywords
- fusioned
- pyrimidins
- bicycle
- fusionated
- akt
- Prior art date
Links
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
ESTA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I), LOS TAUTOMEROS O LOS ESTEREOISOMEROS DE ESTOS, O LAS SALES DE ESTOS, DONDE EL ANILLO B Y LA PIRIMIDINA A LA QUE ESTA FUSIONADO, R4, R5, R6 Y R7 TIENEN LOS VALORES INDICADOS EN LA DESCRIPCION Y LAS REIVINDICACIONES Y SON INHIBIDORES EFICACES DE LA VIA Pi3k/aKT.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1572MU2007 | 2007-08-14 | ||
| EP07118736A EP2050748A1 (en) | 2007-10-18 | 2007-10-18 | Novel fused pyrimidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HN2010000313A true HN2010000313A (es) | 2013-03-18 |
Family
ID=40153211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HN2010000313A HN2010000313A (es) | 2007-08-14 | 2010-02-12 | Pirimidinas biciclicas fusionadas |
Country Status (37)
| Country | Link |
|---|---|
| US (2) | US7776864B2 (es) |
| EP (1) | EP2188291B1 (es) |
| JP (1) | JP5344637B2 (es) |
| KR (1) | KR20100053556A (es) |
| CN (1) | CN101778851B (es) |
| AR (1) | AR067945A1 (es) |
| AU (1) | AU2008288392B2 (es) |
| BR (1) | BRPI0815207A2 (es) |
| CA (1) | CA2694058C (es) |
| CL (1) | CL2008002398A1 (es) |
| CO (1) | CO6260077A2 (es) |
| CR (1) | CR11270A (es) |
| CY (1) | CY1113486T1 (es) |
| DK (1) | DK2188291T3 (es) |
| DO (1) | DOP2010000058A (es) |
| EA (1) | EA020996B1 (es) |
| EC (1) | ECSP109964A (es) |
| ES (1) | ES2396177T3 (es) |
| HN (1) | HN2010000313A (es) |
| HR (1) | HRP20121022T1 (es) |
| IL (1) | IL203163A (es) |
| MA (1) | MA31608B1 (es) |
| MX (1) | MX2010001746A (es) |
| MY (1) | MY169738A (es) |
| NZ (1) | NZ583267A (es) |
| PA (1) | PA8793201A1 (es) |
| PE (1) | PE20090944A1 (es) |
| PL (1) | PL2188291T3 (es) |
| PT (1) | PT2188291E (es) |
| RS (1) | RS52559B (es) |
| SI (1) | SI2188291T1 (es) |
| SV (1) | SV2010003483A (es) |
| TN (1) | TN2010000070A1 (es) |
| TW (1) | TWI439272B (es) |
| UA (1) | UA99735C2 (es) |
| UY (1) | UY31293A1 (es) |
| WO (1) | WO2009021992A2 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008050821A1 (en) * | 2006-10-19 | 2008-05-02 | Takeda Pharmaceutical Company Limited | Indole compound |
| CL2008002398A1 (es) | 2007-08-14 | 2009-07-31 | Bayer Ip Gmbh | Compuestos derivados de 6-(fenil piperidina) pirimidinas fusionadas con imidazol, triazol o pirozol, inhibidores de la via pi3k/akt; composicion farmaceutica; combinacion farmaceutica; y uso de los compuestos para el tratamiento de la neoplasia benigna y/o maligna y para el cancer. |
| MX315904B (es) | 2008-05-30 | 2013-11-29 | Amgen Inc | Inhibidores de fosfoinosituro-3 cinasa. |
| CN102361872B (zh) * | 2009-02-13 | 2014-12-03 | 拜耳知识产权有限责任公司 | 作为akt抑制剂的稠合嘧啶 |
| MA33032B1 (fr) | 2009-02-13 | 2012-02-01 | Bayer Schering Pharma Ag | Pyrimidines condensees |
| US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
| JPWO2010125799A1 (ja) | 2009-04-27 | 2012-10-25 | 塩野義製薬株式会社 | Ｐｉ３ｋ阻害活性を有するウレア誘導体 |
| CN103189379A (zh) * | 2010-07-13 | 2013-07-03 | 拜耳知识产权有限责任公司 | 双环嘧啶 |
| US8987273B2 (en) | 2010-07-28 | 2015-03-24 | Bayer Intellectual Property Gmbh | Substituted imidazo[1,2-B]pyridazines |
| WO2012136776A1 (en) | 2011-04-07 | 2012-10-11 | Bayer Intellectual Property Gmbh | Imidazopyridazines as akt kinase inhibitors |
| AU2014208964B2 (en) | 2013-01-23 | 2016-09-01 | Astrazeneca Ab | Chemical compounds |
| US20140274685A1 (en) | 2013-03-15 | 2014-09-18 | Bayer Cropscience Lp | Compositions, additives, and methods for mitigating or controlling seed dust |
| AU2014232160A1 (en) * | 2013-03-15 | 2015-09-10 | Bayer Cropscience Lp | Compositions, additives, and methods for mitigating or controlling seed dust |
| CN111212839A (zh) | 2017-09-15 | 2020-05-29 | 艾杜罗生物科技公司 | 吡唑并嘧啶酮化合物及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004502691A (ja) | 2000-06-30 | 2004-01-29 | ワイス | 抗癌薬としての置換トリアゾロピリミジン |
| US7449488B2 (en) * | 2002-06-04 | 2008-11-11 | Schering Corporation | Pyrazolopyrimidines as protein kinase inhibitors |
| US7579355B2 (en) | 2003-04-24 | 2009-08-25 | Merck & Co., Inc. | Inhibitors of Akt activity |
| DE602005026509D1 (de) | 2004-04-09 | 2011-04-07 | Merck Sharp & Dohme | Hemmer der akt aktivität |
| AR050188A1 (es) * | 2004-08-03 | 2006-10-04 | Uriach Y Compania S A J | Compuestos heterociclicos condensados utiles en terapia como inhibidores de quinasas p38 y composiciones farmaceuticas que los contienen |
| WO2006036395A2 (en) * | 2004-08-23 | 2006-04-06 | Merck & Co., Inc. | Inhibitors of akt activity |
| AU2005316826A1 (en) | 2004-12-15 | 2006-06-22 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
| JP5274842B2 (ja) * | 2004-12-28 | 2013-08-28 | エグゼリクシス， インコーポレイテッド | 免疫疾患、炎症疾患および増殖疾患の処置のためのセリン−スレオニンキナーゼモジュレーター（ｐ７０Ｓ６Ｋ、Ａｋｔ−１およびＡｋｔ−２）としての［１Ｈ−ピペラゾ［３，４−ｄ］ピリミジン−４−イル］−ピペラジンまたは［１Ｈ−ピペラゾ［３，４−ｄ］ピリミジン−４−イル］−ピペラジン化合物 |
| CN101115479A (zh) | 2005-02-14 | 2008-01-30 | 默克公司 | Akt活性抑制剂 |
| EP1898903B8 (en) | 2005-06-10 | 2013-05-15 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| CL2008002398A1 (es) | 2007-08-14 | 2009-07-31 | Bayer Ip Gmbh | Compuestos derivados de 6-(fenil piperidina) pirimidinas fusionadas con imidazol, triazol o pirozol, inhibidores de la via pi3k/akt; composicion farmaceutica; combinacion farmaceutica; y uso de los compuestos para el tratamiento de la neoplasia benigna y/o maligna y para el cancer. |
| MA33032B1 (fr) * | 2009-02-13 | 2012-02-01 | Bayer Schering Pharma Ag | Pyrimidines condensees |
-
2008
- 2008-08-14 CL CL2008002398A patent/CL2008002398A1/es unknown
- 2008-08-14 EP EP08787224A patent/EP2188291B1/en active Active
- 2008-08-14 ES ES08787224T patent/ES2396177T3/es active Active
- 2008-08-14 RS RS20120556A patent/RS52559B/sr unknown
- 2008-08-14 WO PCT/EP2008/060690 patent/WO2009021992A2/en not_active Ceased
- 2008-08-14 MX MX2010001746A patent/MX2010001746A/es active IP Right Grant
- 2008-08-14 CN CN2008801031086A patent/CN101778851B/zh not_active Expired - Fee Related
- 2008-08-14 UY UY31293A patent/UY31293A1/es not_active Application Discontinuation
- 2008-08-14 US US12/191,703 patent/US7776864B2/en not_active Expired - Fee Related
- 2008-08-14 MY MYPI2010000150A patent/MY169738A/en unknown
- 2008-08-14 NZ NZ583267A patent/NZ583267A/en not_active IP Right Cessation
- 2008-08-14 PT PT87872248T patent/PT2188291E/pt unknown
- 2008-08-14 PE PE2008001378A patent/PE20090944A1/es not_active Application Discontinuation
- 2008-08-14 SI SI200830848T patent/SI2188291T1/sl unknown
- 2008-08-14 HR HRP20121022AT patent/HRP20121022T1/hr unknown
- 2008-08-14 UA UAA201002746A patent/UA99735C2/uk unknown
- 2008-08-14 PL PL08787224T patent/PL2188291T3/pl unknown
- 2008-08-14 JP JP2010520586A patent/JP5344637B2/ja not_active Expired - Fee Related
- 2008-08-14 AU AU2008288392A patent/AU2008288392B2/en not_active Ceased
- 2008-08-14 TW TW097131066A patent/TWI439272B/zh not_active IP Right Cessation
- 2008-08-14 CA CA2694058A patent/CA2694058C/en not_active Expired - Fee Related
- 2008-08-14 KR KR1020107003246A patent/KR20100053556A/ko not_active Abandoned
- 2008-08-14 PA PA20088793201A patent/PA8793201A1/es unknown
- 2008-08-14 DK DK08787224.8T patent/DK2188291T3/da active
- 2008-08-14 EA EA201000298A patent/EA020996B1/ru not_active IP Right Cessation
- 2008-08-14 BR BRPI0815207A patent/BRPI0815207A2/pt not_active IP Right Cessation
- 2008-08-15 AR ARP080103562A patent/AR067945A1/es unknown
-
2010
- 2010-01-06 IL IL203163A patent/IL203163A/en not_active IP Right Cessation
- 2010-02-12 CR CR11270A patent/CR11270A/es unknown
- 2010-02-12 MA MA32617A patent/MA31608B1/fr unknown
- 2010-02-12 CO CO10015919A patent/CO6260077A2/es active IP Right Grant
- 2010-02-12 DO DO2010000058A patent/DOP2010000058A/es unknown
- 2010-02-12 TN TNP2010000070A patent/TN2010000070A1/fr unknown
- 2010-02-12 SV SV2010003483A patent/SV2010003483A/es unknown
- 2010-02-12 EC EC2010009964A patent/ECSP109964A/es unknown
- 2010-02-12 HN HN2010000313A patent/HN2010000313A/es unknown
- 2010-03-25 US US12/731,880 patent/US8614218B2/en not_active Expired - Fee Related
-
2012
- 2012-12-13 CY CY20121101220T patent/CY1113486T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HN2010000313A (es) | Pirimidinas biciclicas fusionadas | |
| DOP2010000057A (es) | Imidazoles fusionados para el tratamiento del cancer | |
| SV2010003598A (es) | Derivados de tiazol usados como inhibidores de pi 3-cinasa | |
| EA201100447A1 (ru) | Органические соединения | |
| NO20090313L (no) | Derivater og analoger av N-etylkinoloner og N-etylazakinoloner | |
| UY32432A (es) | Compuestos de pirimidina fusionada como inhibidores de akt | |
| SV2011003809A (es) | Derivados de heteroarilo como inhibidores de dgat1 | |
| CO6480927A2 (es) | Derivados de imidazolin-2-ona 1,3-disustituida como inhibidores de cyp17. | |
| CR11803A (es) | Pirrolopiridinas como inhibidores de cinasa | |
| ECSP077223A (es) | Indazoles utiles en el tratamiento de enfermedades cardiovasculares | |
| CR10662A (es) | Compuestos de metilpiridopirimidinona | |
| GT200500175A (es) | Inhibidores de cetp | |
| ECSP099078A (es) | Derivados de amino-piperidina como inhibidores de la proteina de transferencia de colesteril-ester (cetp) | |
| NI201000059A (es) | Inhibidores de la cinasa c-fms. | |
| DK2134691T3 (da) | Quinolinonderivativer som parp- og tank-inhibitorer | |
| CY1112102T1 (el) | Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1 | |
| PA8772701A1 (es) | "COMPUESTOS AMINO-5-[-4-(DIFLUOROMETOXI)FENIL SUSTITUIDO)-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA" | |
| ECSP13012600A (es) | CO-cristales y Sales de Inhibidores de CCR3 | |
| ATE517873T1 (de) | 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten | |
| GT201000298A (es) | 2,6-diamino-pirimidin-z-il-carboxamidas como inhibidores de syk o jak quinasas | |
| ME00582A (en) | Tricyclic compound and pharmaceutical use thereof | |
| UY30788A1 (es) | Compuestos quimicos | |
| CO6382113A2 (es) | Compuestos quimicos | |
| CU23955B1 (es) | PIRIMIDINAS BICÍCLICAS FUSIONADAS COMO INHIBIDORES EFECTIVOS DE LA VÍA Pi3K/Akt | |
| HN2010000739A (es) | Inhibidores de quinasa c-fms |